Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate
Clinical trial NCT00041613 · UNKNOWN
Trial details
- NCT number
- NCT00041613
- Sponsor
- Introgen Therapeutics
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.